9. Accrued Expenses
Accrued expenses consist of the following as of December 31, 2020 and 2019 (in thousands):
December 31, 2020
December 31, 2019
External research and preclinical development
$
4,702
5,395
Employee compensation and benefits
5,715
4,174
Professional fees
602
694
Facilities and other
65
383
11,084
10,646
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
No definition available.